-
Bloomberg—President Donald Trump is considering executive action to cut drug prices ahead of the 2020 election, officials familiar with the matter say, as he enters his re-election seeking to rebut Democratic criticism that his policies have hurt healthcare consumers.February 11
-
The Food and Drug Administration has launched a mobile-friendly database offering clinicians and patients information on antiretrovirals, which are HIV drugs.January 30
-
Surescripts is taking steps to automate the forms required for specialty medications and integrating them into the e-prescribing process.January 29
-
Health IT vendor Practice Fusion, owned by Allscripts, has reached an agreement with the Department of Justice to resolve criminal and civil investigations related to its electronic health records software.January 28
-
While machine learning has the potential to identify new treatments, reduce failure rates in clinical trials and improve drug development, a lack of high-quality data is hindering the use of the technology.January 21
-
A U.S. Senator is calling for the Drug Enforcement Administration to stop delaying providers from being able to treat patients using telehealth.January 20
-
The University of Pittsburgh Medical Center’s venture capital and commercialization arm will invest $1 billion over the next five years to advance promising new therapeutics, diagnostics and devices.January 14
-
Augmented intelligence vendor nference has been selected by the Mayo Clinic to apply advanced analytics to de-identified clinical and molecular data, as well as biomedical literature, to improve patient care.January 14
-
The Department of Health and Human Services has entered into an agreement with Millennium Health to provide real-time drug testing data to help counter overdoses nationwide.January 7
-
The momentum behind digital therapeutics appears to be advancing, despite some chilling of relationships between vendors of the products and pharmaceutical companies.January 3
